WNT3A and myocardial infarction: Oikonomopoulos et al. studied the effects of recombinant WNT3a (r-WNT3a) administered via injections in the border zone of the infarct area, immediately after the induction of permanent MI by occlusion of the Left Anterior Descending (LAD) coronary artery.